Best Practices and Research Advances in Thoracic Oncology: A Regional Series SE Asia Course 3: Driver Alterations in Lung Cancer-Molecular Profiling: Research and Networking in the Region

Molecular Profiling: Research and Networking in the Region

Video Transcription

Video Summary

Koichi Goto from the National Cancer Center outlines the LC-SCRAM-ASIA project, a genomic screening platform aiming to enhance precision medicine for lung cancer in Asian countries. Based in Japan, the platform is supported by numerous pharmaceutical companies and has seen significant participation from institutions and patients, resulting in a comprehensive genomic database. LC-SCRAM-ASIA has effectively identified various mutations and supported the approval of multiple targeted therapies, such as crosotinib and selpercatinib. The initiative has expanded its reach to several Asian Pacific countries, providing free genomic analysis and establishing a robust foundation for precision medicine in the region.

Asset Subtitle

Koichi Goto, MD, PhD

Keywords

genomic screening

precision medicine

lung cancer

LC-SCRAM-ASIA

targeted therapies